Environmental Communications

Sumitomo Pharma conducts a variety of environmental education initiatives aimed at giving employees a broad knowledge of environmental challenges such as global warming, as well as getting employees to participate in a wide range of environmental conservation activities not only within the company but also at home and in their communities. In April each year we provide new employees with education focused on global environmental challenges and Sumitomo Pharma's environmental conservation activities. We also conduct appropriate environmental education for employees in plants and research laboratories, while raising employees' awareness in other workplaces through environmental education and events geared to each site. Moreover, during Environment Month each June, we raise awareness through a message from the Chair of the Environmental and Safety Committee and our e-learning program on environmental education for all employees. During the Environment Month in fiscal 2022, employees learned about "water risk" and were educated that each one of them should treat "water risk" as their own concern and be prepared for it.

As institutional investors become increasingly interested in companies' environmental, social, and governance-related (ESG) performances, we engage in more appropriate disclosure of environmental information and have a dialogue with institutional investors. Since fiscal 2018, we have held ESG Meetings annually to enhance investors' and analysts' understanding of our environmental initiatives, hear the opinions of investors, and reflect them in future initiatives. The meeting for fiscal 2021 was held on December 8 2021.
Click here (Investor Relations "Presentation/ Webcast") for details of ESG Meetings

Sumitomo Pharma and its group companies in Japan (6 companies in fiscal 2021) have an annual meeting to exchange information on environment and safety to enhance levels of management in these areas. In fiscal 2021, six group companies participated. Moreover, we conduct an environment, health and safety (EHS) audit at Japanese group companies and the Suzhou plant of Sumitomo Pharma (Suzhou) Co., Ltd. in China, our only overseas group company that has production functions, and we confirm compliance with various laws and regulations and fair and appropriate implementation of voluntary environmental and safety activities. In principle, we conduct EHS audits at two Japanese group companies each year. As for the Suzhou plant, we conducted the EHS audit in fiscal 2019.